research SARS-CoV-2 and Androgenic Alopecia: Exploring Links
Possible link between COVID-19 and hair loss; more research needed.
Search
for
Sort by
Research
420-450 / 1000+ results 
research Association Between Alopecia Areata and COVID-19: A Systematic Review
COVID-19 may be linked to hair loss or worsening of hair loss in some people.
research Androgenetic Alopecia and COVID-19: Is There a Clinical Connection?
Androgenetic alopecia severity does not affect COVID-19 severity.
research Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.
research Role of ACE2 Polymorphism in COVID-19: Impact of Age
Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.
research Not Just Thinning: A Case of Alopecia Universalis After Mild COVID-19
A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.
research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
research Analysis and Clinical Determinants of Post-Covid-19 Syndrome in the Lombardy Region: Evidence From a Longitudinal Cohort Study
The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.
research Evaluating the Role of COVID-19 Vaccines in the Landscape of Medication-Induced Alopecia Areata
The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.
research 2022 Practice Census Shows Impact of COVID-19 Pandemic on Hair Restoration
The COVID-19 pandemic affected hair restoration practices in 2022.
research Safety and Efficacy of the COVID-19 Vaccine in Children and Adolescents: A Meta-Analysis
COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.
research Cross-Sectional Survey Examining Skin Picking and Hair Pulling Disorders During the COVID-19 Pandemic
The COVID-19 pandemic increased symptoms in people with skin picking and hair pulling disorders.
research Impact of Androgen Deprivation Therapy on Mortality of Prostate Cancer Patients with COVID-19: A Propensity Score-Based Analysis
Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.
research Cutaneous Manifestations of COVID-19
COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.
research Dermatological Manifestations of Patients with COVID-19: A Cross-Sectional Study
COVID-19 can cause skin problems.
research Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.
research Covid-19 and Male Androgenetic Alopecia: Systematic Investigation of a Potential Epidemiological and Genetic Association
No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.
research Post Severe COVID-19 Infection Lung Damage Study: The Experience of Early Three Months Multidisciplinary Follow-Up
After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.
research Post-Acute COVID-19 Sequelae – 'COVID Long Hauler'
Long COVID causes lasting symptoms and needs ongoing care.
research Enanthem in Patients With COVID-19 and Skin Rash
Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.
research A Synbiotic Preparation (SIM01) for Post-Acute Covid-19 Syndrome in Hong Kong (Recovery): A Randomised, Double-Blind, Placebo-Controlled Trial
SIM01 significantly reduced post-COVID symptoms and is safe.
research Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.
research Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.
research Persistent Post COVID-19 Symptoms and Functional Status After 12-14 Weeks of Recovery, Tamil Nadu, India, 2021
One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.
research Intra-Host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations
Some early COVID-19 mutations in patients predicted future common virus mutations.
research Dermatological Manifestations Associated With the Severity of COVID-19 Infection: A Retrospective Cross-Sectional Observational Study of 144 Patients
Certain skin symptoms in COVID-19 patients may indicate a more severe illness.
research Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine Prescribed for COVID-19
A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.
research The Use of Mesenchymal Stromal Cells in the Treatment of Coronavirus Disease 2019
Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.
research MAIT Cells in COVID-19: Heroes, Villains, or Both?
MAIT cells may help fight COVID-19 but also contribute to severe inflammation.
research Prevalence and Predictors of Persistent Post-Covid-19 Symptoms
Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.